1. Home
  2. KOD vs CXDO Comparison

KOD vs CXDO Comparison

Compare KOD & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • CXDO
  • Stock Information
  • Founded
  • KOD 2009
  • CXDO 1995
  • Country
  • KOD United States
  • CXDO United States
  • Employees
  • KOD N/A
  • CXDO N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • CXDO Telecommunications Equipment
  • Sector
  • KOD Health Care
  • CXDO Telecommunications
  • Exchange
  • KOD Nasdaq
  • CXDO Nasdaq
  • Market Cap
  • KOD 115.0M
  • CXDO 137.0M
  • IPO Year
  • KOD 2018
  • CXDO 1998
  • Fundamental
  • Price
  • KOD $3.77
  • CXDO $5.64
  • Analyst Decision
  • KOD Hold
  • CXDO Strong Buy
  • Analyst Count
  • KOD 3
  • CXDO 2
  • Target Price
  • KOD $9.00
  • CXDO $8.75
  • AVG Volume (30 Days)
  • KOD 468.9K
  • CXDO 126.9K
  • Earning Date
  • KOD 05-19-2025
  • CXDO 05-06-2025
  • Dividend Yield
  • KOD N/A
  • CXDO N/A
  • EPS Growth
  • KOD N/A
  • CXDO 51.44
  • EPS
  • KOD N/A
  • CXDO 0.09
  • Revenue
  • KOD N/A
  • CXDO $62,609,000.00
  • Revenue This Year
  • KOD N/A
  • CXDO $13.25
  • Revenue Next Year
  • KOD N/A
  • CXDO $11.35
  • P/E Ratio
  • KOD N/A
  • CXDO $63.51
  • Revenue Growth
  • KOD N/A
  • CXDO 13.85
  • 52 Week Low
  • KOD $1.92
  • CXDO $2.92
  • 52 Week High
  • KOD $11.60
  • CXDO $7.34
  • Technical
  • Relative Strength Index (RSI)
  • KOD 50.83
  • CXDO 62.73
  • Support Level
  • KOD $3.66
  • CXDO $5.08
  • Resistance Level
  • KOD $4.20
  • CXDO $5.71
  • Average True Range (ATR)
  • KOD 0.49
  • CXDO 0.31
  • MACD
  • KOD 0.00
  • CXDO 0.12
  • Stochastic Oscillator
  • KOD 25.14
  • CXDO 95.24

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

Share on Social Networks: